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Oxidative stress has been implicated in cell death in range of disease states including ischemia/reperfusion injury of the heart and heart failure.
Here we have investigated the mechanisms of cell death following chronic exposure of cardiac myocytes to oxidative stress initiated by hydrogen
peroxide. This exposure induced a delayed form of cell death with ultrastructural changes typical of necrosis, and that was accompanied by the
release of lactate dehydrogenase and increased lipid peroxidation. However, this delayed death was not accompanied by the loss of mitochondrial
membrane potential or caspase-3 activation. Furthermore, we could demonstrate that this delayed necrosis was at least partially prevented by pre-
treatment with the hypertrophic stimuli endothelin-1 or leukemic inhibitory factor. Our results suggest that this delayed form necrosis may also
comprise an ordered series of events involving pathways amenable to therapeutic modulation.
© 2006 Elsevier B.V. All rights reserved.Keywords: Necrosis; Energy stress; Caspase activity; Lipid peroxidation; Antioxidants1. Introduction
Reactive oxygen species (ROS) play a role in mediating a
wide range of diseases such as atherosclerosis, cancer,
neurodegeneration and immunological disorders [1]. In these
situations, the rates of ROS production appear to exceed the
rates of ROS removal and thus the net effect is an increased
level of ROS. The resulting oxidative stress has been implicated
in cell death in cardiac pathologies such as ischemia/reperfusion
injury [2] and heart failure [3].
The essential features of apoptotic and necrotic death were
originally delineated more than 30 years ago [4]. Specifically,
apoptosis has been considered to be an active and regulated
form of cell death requiring maintained intracellular ATP
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condensation and DNA fragmentation into discrete oligonu-
cleosomal fragments [4]. In contrast, necrosis has been
considered to be an accidental, uncontrolled and passive form
of cell death that is accompanied by intracellular ATP depletion
[5]. Necrosis is also morphologically distinct from apoptosis
and is characterized by cellular swelling, plasma membrane
rupture and the subsequent loss of cytoplasmic contents [6].
However, more recently the exact delineation of apoptosis and
necrosis has been increasingly challenged, with the emerging
idea that there may be a spectrum of cell death processes [7,8].
Thus, terms such as necrapoptosis have been used to emphasize
shared features in necrotic and apoptotic cell death [9].
ROS production has been increasingly implicated as either a
trigger or mediator of cell death. Thus, exposure to low levels of
hydrogen peroxide (H2O2, 10–100 μM) induces apoptosis in
primary cultures of neonatal cardiac myocytes, with this form of
cell death and its mediators now being extensively studied [10–
12]. In contrast, very little is known about oxidative stress-
induced necrosis and few studies have provided measures of the
death of cardiac myocytes by necrosis. Thus, the importance of
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been largely overlooked in favour of studies on cardiac myocyte
apoptosis. The importance of understanding necrotic death is
further emphasized by recent studies that have challenged the
traditional concept that necrosis is an accidental and uncon-
trolled form of cell death [13–15]. These studies instead suggest
that necrosis is an ordered event involving cellular signalling
pathways and/or the activation of enzymes such as calpains and
cathepsins as mediators of the cell death processes. Importantly
these findings indicate that necrotic cell death occurs via a
sequential series of events and that this process is not
instantaneous. This challenges the traditional views of necrotic
cell death and furthermore suggests that it may be possible to
prevent necrotic cell death [16,17]. Therefore, our study was
designed to investigate the effect of oxidative stress on cardiac
myocyte viability, specifically focusing on necrotic death of
these cells.
Oxidative stress-induced necrosis has previously been
considered to be caused by mitochondrial dysfunction involving
sustained mitochondrial permeability transition pore (MPTP)
opening and ATP depletion [18,19]. However, the results from
our study demonstrate that an alternative pathway to necrosis
exists which involves neither MPTP opening nor ATP
depletion. Instead, our results demonstrate that exposure of
cardiac myocytes to H2O2 (200 μM) induces a delayed form of
necrotic cell death that is associated with increased lipid
peroxidation. Furthermore, we demonstrate that H2O2-induced
necrotic death is at least partially preventable following chronic
exposure of cardiac myocytes to the hypertrophic agents
endothelin-1 (ET-1) or leukemic inhibitory factor (LIF). Taken
together, our results suggest that strategies should be directed at
the control of necrotic cell death of cardiac myocytes and that
such strategies may offer important therapeutic approaches in
the treatment of a range of cardiovascular diseases previously
considered beyond the realm of anti-apoptotic approaches.
2. Materials and methods
2.1. Isolation and culture of neonatal cardiac myocytes
Cardiac myocytes from neonatal Sprague–Dawley rats (1 day old) were
isolated as described previously [20]. Cells were resuspended in Dulbecco's
modified Eagle's media (DMEM):M199 (4:1) containing 10% (v/v) horse
serum, 5% (v/v) heat inactivated fetal bovine serum, 10 μM cytosine-D-arabino-
furanoside, 5 mM creatine and 80 U/ml penicillin/streptomycin and pre-plated
for 45 min to remove non-cardiac myocytes. The cardiac myocytes were plated
onto gelatin-coated 35-mm dishes or 6-well culture plates (750 000 cells in 2 ml)
and cultured for 18–24 h before the media was changed to serum-free DMEM
containing 5 mM creatine and 100 U/ml penicillin/streptomycin. The cardiac
myocytes were cultured in serum-free media for 24 h prior to further treatment.
2.2. Transmission electron microscopy (TEM)
Twenty-four hours after the addition of either H2O2 (200 μM) or
doxorubicin (2 μM), cardiac myocytes were fixed in 2.5% (v/v) glutaralde-
hyde/4% (v/v) paraformaldehyde, post-fixed in 1% (v/v) osmium tetroxide,
dehydrated in graded ethanols, cleared in propylene oxide and embedded in
Araldite. Ultrathin sections (∼70 nm) were cut and counterstained with uranyl
acetate and lead citrate and viewed under a JEOL 2000FX-2 transmission
electron microscope.2.3. Measurement of lactate dehydrogenase (LDH) release
Cardiac myocyte plasma membrane integrity was assessed following
exposure to either H2O2 (200 μM) or doxorubicin (2 μM) by measuring the
release of LDH into the culture medium. Sub-samples (75 μl) of media were
removed from the cultures at the indicated time points and then cells were lysed
in 1% (v/v) Triton X-100 in DMEM at the completion of each experiment to
estimate the remaining cellular content of LDH. The LDH assay reagent (2.8 μM
NADH, 7 mM pyruvate, 0.35% (v/v) BSA in 0.35 M Imidazole buffer (pH 7);
25 μl) was added to sub-samples (150 μl) diluted 5-fold in 0.067% (v/v) Triton
X-100 in DMEM or the cell lysates (150 μl) diluted 15-fold in DMEM. The rate
of decrease in absorbance was measured at 340 nm in a Spectra Max 340 over
15 min at 37 °C. The LDH activity in each sub-sample was expressed as a
percentage of total LDH activity.
Release of LDH was used to estimate cell death following cardiac
myocyte exposure to 200 μM H2O2 in subsequent experiments. In these
experiments a variety of pre-treatments (30 min to 24 h as indicated) were
tested for the ability to prevent LDH release, and these included cyclosporin
A (CsA, 1.5 μg/ml, 30 min) as an inhibitor of mitochondrial permeability
transition opening, N-acetyl-Leu-Leu-norleucinal (ALLN, 50 μM, 6 h) as an
inhibitor of calpain 1 activation, pepstatin A (10 μM, 6 h) as an inhibitor of
cathepsin D activation, trolox (30 μM, 30 min) as a water-soluble vitamin E
analog, or dipyridyl (100 μM, 30 min) as an iron chelator. Similarly, we
tested the protective effects of 48 h pre-treatment with either ET-1 (100 nM)
or LIF (10 ng/ml). Under these conditions, these two stimuli induce cardiac
myocyte hypertrophy [21].
2.4. Caspase-3 activity assay
Caspase-3 activity was measured following the exposure of cardiac
myocytes to either H2O2 (200 μM) or doxorubicin (2 μM) using a
modification a method described previously [22]. Briefly, cardiac myocytes
were rinsed twice in ice-cold PBS, lysed on ice in lysis buffer (125 μM
EDTA, 5% (v/v) glycerol in 12.5 mM Tris–HCl (pH 7.0)) and sonicated
(10×1 second bursts). Samples were centrifuged (10,000×g, 10 min) and the
supernatant was retained for determination of caspase-3 activity and protein
concentration. The pellet was solubilized in 0.3 M NaOH and retained for
determination of protein concentration. Caspase-3 activity was determined in
samples (50 μl) following the addition of assay reagent (0.5 mM EDTA, 20%
(v/v) glycerol, 4 mM dithiothreitol, 20 μM Ac-DEVD-AMC in 50 mM Tris
(pH 7.0), 50 μl) by measuring the cleavage of the fluorescent substrate, Ac-
DEVD-AMC (Sigma Chemical Company, St. Louis, Missouri, USA) in a
FLUOstar (BMG Labtech).
2.5. Mitochondrial membrane potential (MMP) measurements
Cells were grown in 6-well culture plates and mitochondrial membrane
potential (MMP) was measured in a FLUOstar (BMG Labtech) at 37 °C.
Specifically, MMP was measured using 5, 5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-
tetraethylbenzimidazolocarbocyanineiodide (JC-1; 640 nM). We found that
MMPwas best described by using the ratio of fluorescent emission at 590 nm (J-
aggregate emission)/520 nm (monomeric form of JC-1), after excitation at
485 nm. Cells were loaded with JC-1 for 2 h before dishes were washed three
times in NaHCO3-free DMEM (pH 7.4) and experiments started by the addition
of H2O2. To determine background fluorescence, at the end of the experiment
the mitochondrial protonophore carbonyl cyanide p-trifluoromethoxyphenylhy-
drazone (FCCP, 2.8 μM) and the mitochondrial complex III inhibitor
myxothiazol (20 μM) were added and the recording continued for a further
25 min.
2.6. Analytical measurements
Intracellular ATP, PCr and creatine concentrations were determined
fluorometrically in the FLUOstar (BMG Labtech) at 460 nm, after excitation
at 355 nm, using methods described previously [23,24]. Protein concentrations
were determined using the Bio-Rad Protein Assay Kit using bovine serum
albumin as the standard protein.
Fig. 1. Ultra-structural analysis reveals features of necrotic death of cardiac
myocytes following prolonged exposure to H2O2 but apoptotic death following
exposure to doxorubicin. Cultured cardiac myocytes were (A) untreated to act as
a control, (B) treated for 24 h with H2O2 (200 μM) or (C) treated for 24 h with
doxorubicin (2 μM). Samples were processed for transmission electron
microscopy. In all panels, ultrastructural features are indicated as N (nucleus)
and Mt (mitochondria), whilst in (B) the arrows indicate regions of plasma
membrane disruption and in (C) vacuoles are indicated by V. This analysis was
completed on 3 independent occasions and up to 100 cells were examined.
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Lipid peroxidation was assessed using Bodipy® 581/591 C11, a fluorescent
fatty acid analogue which localizes to cell membranes [25]. Increased lipid
peroxidation is associated with increased Bodipy® 581/591 C11 fluorescence
(excitation 485 nm, emission 520 nm). Cardiac myocytes were incubated with
10 μMBodipy® 581/591 C11 for 60 min. Immediately prior to addition of H2O2,
cells were rinsed three times in DMEM. Cells were lysed on ice in lysis buffer
(3.2 mM ascorbic acid, 90% (v/v) ethanol in 50 mM Tris–HCl (pH 7.5); 1 ml)
and immediately centrifuged (5000×g, 5 min at 4 °C). The supernatant was
removed and Bodipy® 581/591 C11 oxidation was determined in the FLUOstar
(BMG Labtech), while the pellet was solubilized in 0.3 M NaOH and retained
for protein concentration determination.
2.8. Statistical analysis
Results are expressed as mean±S.E.M. for n=3 to n=8 experiments
performed on independent cardiac myocyte preparations. Data were analysed by
repeated-measures ANOVA, with statistical differences being determined by
least significant difference post hoc tests. Data were considered significantly
different at P<0.05.
3. Results
3.1. H2O2 induces delayed death of cardiac myocytes that
shares features with necrosis but not apoptosis
Due to the increasing interest in the effects of oxidative stress
on cardiac myocytes [26], we first exposed cultured cardiac
myocytes to 200 μMH2O2. Within 24 h, these cardiac myocytes
showed signs of cell death and we characterized the features of
this death further. First, the ultrastructural consequences of this
chronic exposure of cardiac myocytes to H2O2 were examined
by TEM. During this analysis, specific attention was directed to
an evaluation of any changes typical of cell death by necrosis or
apoptosis. Control cardiac myocytes displayed a normal
ultrastructure with organelles such as mitochondria appearing
intact (Fig. 1A). In contrast, cardiac myocytes treated for 24 h
with 200 μM H2O2 were ultrastructurally distinct, with
organelles including mitochondria appearing swollen and the
plasma membrane displaying multiple areas of disruption (Fig.
1B). These features are typical of necrotic cells [27]. Thus, these
results suggest that exposure to 200 μM H2O2 induces necrotic
death of cardiac myocytes under these conditions.
As a positive control to evaluate the ultrastructural features
of cardiac myocytes undergoing apoptosis, we also exposed
cardiac myocytes to 2 μM doxorubicin for 24 h. Doxorubicin is
a quinone-containing anthracycline that accumulates in the
mitochondria [28,29] and it has previously been shown to
induce apoptosis in cardiac myocytes [30]. The mechanism by
which doxorubicin induces apoptosis is thought to involve the
generation of free radicals through redox cycling of doxorubicin
[31]. TEM revealed that cardiac myocytes exposed to
doxorubicin exhibited an apoptotic ultrastructure characterized
by cytoplasmic shrinkage, an intact plasma membrane, nuclear
condensation and the appearance of vacuoles (Fig. 1C).
Therefore, the features of cardiac myocytes in the presence of
200 μM H2O2 were distinctly different from the features of
cardiac myocytes undergoing apoptotic death in the presence of
2 μM doxorubicin.We further confirmed that exposure to H2O2 resulted in
cardiac myocyte necrosis and not apoptosis by measuring both
the release of LDH and the activity of caspase-3. Increased LDH
release was used as an indicator of necrosis due to the leakiness
Fig. 3. Caspase-3 activity is increased in doxorubicin-treated cardiac myocytes
but not H2O2-treated cardiac myocytes. Caspase-3 activity was measured as an
indicator of apoptotic cell death using the fluorescent substrate Ac-DEVD-AMC
following 30 min, 2 h, 6 h and 24 h exposure of cultured cardiac myocytes to
200 μM H2O2 or 2 μM doxorubicin. The results were expressed as caspase-3
activity per mg of cellular protein *P<0.05, (n=4).
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released were significantly increased by 29%, 37% and 40% at
2, 6 and 24 h after the addition of H2O2, respectively (Fig. 2).
These results again suggested that H2O2 induced a necrotic form
of death in these cells. Importantly, LDH release was not
significantly increased 30 min after the addition of H2O2,
thereby demonstrating that this concentration of H2O2 induced a
delayed and not an instantaneous form of necrosis. In contrast,
exposure to the pro-apoptotic stimulus, doxorubicin, only
induced a significant increase in LDH release after 24 h (Fig.
2). The effects of H2O2 and doxorubicin on caspase-3 activation
were also investigated because caspase-3 activity has been
previously been shown to increase during cardiac myocyte
apoptosis [8]. Consistent with the observations in Figs. 1 and 2,
H2O2-induced death was not associated with significant
increases in caspase-3 activity, while doxorubicin increased
caspase-3 activity by 2.7-fold and 4.9-fold after 6 and 24 h,
respectively (Fig. 3). These results further support the
suggestion that the exposure of cardiac myocytes to H2O2
induces their necrosis, and not apoptosis.
3.2. H2O2-induced necrosis is not accompanied by
mitochondrial dysfunction
ROS have been reported to promote MPTP opening [32], and
this event is thought to trigger cell death by both necrosis and
apoptosis [9,33]. In particular, sustained MPTP opening has
been associated with necrotic death, whereas a transient opening
has been associated with apoptotic death [19]. We tested this
hypothesis by evaluating the effects of CsA, an inhibitor of
MPTP opening [34], in our cell culture system. Pre-treatment for
30 min with CsA (1.5 μg/ml) failed to protect cells from H2O2-
induced necrosis (Fig. 4A). This suggested that the MPTP was
not involved in this necrotic cell death. Since MPTP opening
leads to mitochondrial depolarisation (35), we also evaluated theFig. 2. Release of LDH confirms membrane disruption of H2O2-treated
cardiac myocytes but not doxorubicin-treated cardiac myocytes. LDH release
was assayed following 30 min, 2 h, 6 h and 24 h exposure of cultured cardiac
myocytes to 200 μM H2O2 or 2 μM doxorubicin. The results are expressed as
the % LDH released when compared to the total cellular LDH activity.
*P<0.05, (n=4).effect of H2O2 on MMP using the dye JC-1. Exposure of
cardiomyocytes to H2O2 for up to 90 min did not result in a loss
ofMMP as judged by the maintenance of JC-1 fluorescence over
this time (Fig. 4B). However, as a control we could disruptMMP
and thus the recorded JC-1 fluorescence by the addition of
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP)
and myxothiazol that act as a mitochondrial protonophore and a
mitochondrial complex III inhibitor, respectively (Fig. 4B).
Importantly, levels of LDH release were significantly increased
by 30% and 32% after 60 min and 90 min exposure to H2O2,
respectively (results not shown). Therefore, these results
demonstrate that at time points when H2O2-induced necrotic
cardiacmyocyte death is observed there is no significant opening
of the MPTP or loss of mitochondrial membrane potential.
3.3. H2O2-induced cell death is not associated with energetic
stress
One prominent model for necrotic cell death suggests a pivotal
role for ATP depletion as a consequence of mitochondrial
dysfunction as an event preceding cell death [18,19]. In this
situation, damage to the mitochondria would be expected to lead
to a decrease in the rate of ATP production. Consequently, an
imbalance between rates of ATP production and rates of ATP
utilisation would result in energetic stress and ATP levels would
fall below that required for ATP-dependent reactions in the cell.
When we assessed ATP concentrations, exposure of cardiac
myocytes to 200 μMH2O2 caused only a transient decline in ATP
levels, with ATP concentrations being significantly reduced by
58% and 55% after 30 min and 2 h, respectively (Fig. 5A). Six
hours after the addition of H2O2, ATP concentrations had
recovered and were reduced by only 23%. By 24 h, ATP
concentrations were not significantly different from those
measured in control cells and had recovered to within 89% of
the control levels (Fig. 5A). That H2O2-induced cell death was
associated with only a transient decrease in cellular ATP suggests
that this form of cell death is not associated with ATP depletion.
To further verify that ATP depletion did not lead to H2O2-
induced cell death we next measured the concentration of ADP
Fig. 5. Treatment of cardiac myocytes with H2O2 does not cause sustained
energetic stress. Cardiac myocytes were treated with H2O2 (200 μM) for 30 min,
2 h 6 h or 24 h. Cellular energy status was assessed by estimating (A) the
intracellular concentrations of ATP and (B) the intracellular concentrations of
ADPfree. *P<0.05, (n=4).
Fig. 4. H2O2 -induced necrotic death of cardiac myocytes is not prevented by
exposure to the inhibitor of MPTP opening, CsA, and is not accompanied by a
loss of mitochondrial membrane potential. (A) To test the role of the MPTP
opening, cardiac myocytes were pre-treated with CsA (1.5 μg/ml) for 30 min.
LDH released into the culture media was measured as an indicator of cardiac
myocyte necrotic death following 2 h, 6 h and 24 h exposure of cultured cardiac
myocytes to 200 μM H2O2. The results are expressed as the % LDH released
when compared to the total cellular LDH activity. *P<0.05, (n=4). (B) Cardiac
myocytes were loaded with dye JC-1 (600 nM) for 120 min before experiments
were started by the addition of H2O2 (200 μM). JC-1 fluorescence was assessed
in both control and H2O2-treated (200 μM) cardiac myocytes and no significant
difference was noted over the ensuing 95 min. To determine background
fluorescence, myxothiazol (20 μM) and FCCP (2.8 μM) were added at 95 min
(as indicated by the arrow) and incubated with cells for a further 25 min. This
background was then subtracted from all data points, and the final results
expressed as the percentage of fluorescence at t=0, (n=4).
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balance between the rate of synthesis of ATP and its rate of
utilisation by the cell. If the rate of synthesis of ATP is less than
the rate of ATP utilisation by the cell then the concentration of
ADPfree will increase. Alternatively, ADPfree concentrations
will not change if the balance between the rates of ATP
synthesis and ATP utilisation are maintained.
ADPfree cannot be measured directly but can be estimated
from ATP concentrations and the ratio of PCr/Cr by the
following formula [ADPfree]=[ATP]×[creatine] / [PCr]×[H
+]×
[KCK], where KCK is 177 at pH 7.0 and 1 mM Mg
2+
free [36]. To
test the validity of this approach we used sub-lethal concentra-
tions of myxothiazol to cause an imbalance between the synthesis
of ATP by the mitochondria and the use of ATP by the cell. As
expected, myxothiazol caused significant decreases and increases
in intracellular concentrations of ATP and ADPfree, respectively(Fig. 6A and B). Since levels of LDH release were not
significantly increased at any time point (Fig. 6C), our results
demonstrate that this energy stress did not lead to necrotic cell
death. In contrast to cells treated with myxothiazol, there were no
significant increases in ADPfree concentrations in cells treated
with H2O2 (Fig. 5B). These results confirm that ATP depletion
did not lead to H2O2-induced cell death and thereby suggest that
treatment of cardiac myocytes with H2O2 did not affect the ability
of mitochondria to produce ATP.
3.4. Effect of calpain or cathepsin inhibitors on H2O2-induced
LDH release
Calpains and cathepsins have been implicated as key
mediators of necrotic cell death [37]. We therefore next
determined whether inhibition of either of these proteases was
able to protect cardiac myocytes from H2O2-induced necrosis.
Our results demonstrate that LDH release was not reduced in
cells pre-incubated with either an inhibitor of calpain activation
(ALLN) or an inhibitor of cathepsin D activation (pepstatin A)
(Fig. 7). Thus, the cell death initiated by H2O2 does not appear
to require calpain 1 or cathepsin D activation.
3.5. Effects of antioxidants on lipid peroxidation and LDH release
Lipid peroxidation, caused by oxidative stress, has been
implicated in causing cell death [38]. Consequently the effect of
H2O2 on lipid peroxidation was measured using Bodipy® 581/
591 C11, a fluorescent fatty acid analogue which localizes to cell
membranes [39]. Lipid peroxidation was increased following
30 min exposure of the cardiac myocytes to 200 μM H2O2 and
Fig. 7. Inhibition of the protease activities of calpains or cathepsins does not
reduce H2O2 -induced necrotic death of cardiac myocytes. Cardiac myocytes
were pre-treated for 6 h with either an inhibitor of calpain activation, ALLN
(50 μM), or an inhibitor of cathepsin D activation, pepstatin A (10 μM), then
exposed to H2O2 (200 μM) for up to 24 h. LDH released into the culture media
was measured as an indicator of cardiac myocyte necrotic death. The results are
expressed as the % LDH released when compared to the total cellular LDH
activity. *P<0.05, (n=4).
Fig. 6. Cardiac myocyte energy status is affected by the mitochondrial complex
III inhibitor myxothiazol but this does not result in LDH release. Cardiac
myocytes were treated with myxothiazol (20 μM) for 30 min, 2 h, 6 h and 24 h.
Cellular energy status was assessed by estimating (A) the intracellular
concentrations of ATP and (B) the intracellular concentrations of ADPfree.
*P<0.05, (n=3). (C) As an indicator of necrotic cell death, LDH release was also
measured and not found to increase.
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Trolox, a water soluble analogue of Vitamin E, able to prevent
lipid peroxidation [40], was tested for its effectiveness in
preventing cell death. Trolox at a concentration of 30 μM was
effective in preventing H2O2-induced lipid peroxidation at 2 and
24 h (Fig. 8A). This concentration of trolox was also effective in
preventing H2O2-induced necrosis over the 24-h period (Fig.
8B). Iron mediated oxidation was a likely cause of lipid
peroxidation, so the effectiveness of the iron chelator dipyridyl
was tested for its effectiveness in preventing cell death.
Dipyridyl effectively prevented H2O2-induced lipid peroxida-
tion and cell death (Fig. 8A and B). Thus two unrelated
inhibitors, which prevent lipid peroxidation by different mecha-
nisms, were effective in preventing cell death. Therefore, lipid
peroxidation appears to be a contributing event in the H2O2-
induced necrosis observed in these cardiac myocytes.
3.6. ET-1 and LIF inhibit H2O2-induced necrosis in cardiac
myocytes
We recently have described changes in the proteomic profiles
of cardiac myocytes exposed for 48 h to the hypertrophic agents
ET-1 or LIF (21). Proteins that increased in abundance in ET-1treated cells included peroxiredoxin 3 and αB crystallin or in
LIF-treated cells these included Heat shock proteins 20 and 60
as well as Cu/Zn superoxide dismutase [21]. Such changes may
alter the survival of these cells following exposure to H2O2. We
therefore tested whether pre-treatment of cardiac myocytes with
either ET-1 or LIF altered cell death, and our results indicated
significant reductions in the levels of H2O2-induced LDH
release (Fig. 9). This suggests that approaches based on
hormone or cytokine treatments such as these will provide
new means for protection of cardiac myocytes from this delayed
necrotic death following chronic exposure to oxidative stress.
4. Discussion
Necrotic cell death is widely viewed as an uncontrolled,
unordered and irreversible form of cell death resulting from the
depletion of intracellular ATP [8,41]. However increasing
evidence challenges this notion, indicating instead that necrosis
may be an ordered and possibly preventable event [7,13–16,37].
Our study was designed to determine whether cardiac myocytes
undergo necrosis after exposure to oxidative stress and whether
this form of cell death can be a regulated and preventable process.
4.1. H2O2 induces necrotic cell death in cardiac myocytes
Our study demonstrates that low levels of H2O2 induce
necrosis rather than apoptosis in cardiac myocytes. In contrast to
our findings, several studies have previously shown that cardiac
myocytes undergo apoptosis when exposed to low levels of
H2O2 [10–12]. Those observations of apoptotic death and not
necrotic cell death of cardiac myocytes may be explained by the
absence of measures of necrosis and thus its contribution to cell
Fig. 9. Prolonged pre-treatment of cardiac myocytes with the hypertrophic
agents ET-1 or LIF reduces H2O2 -induced necrotic death of cardiac myocytes.
Cardiac myocytes were pre-treated for 48 h with the hypertrophic agents ET-1
(100 nM) or LIF (10 ng/ml) then exposed to H2O2 (200 μM) for up to 24 h. LDH
released into the culture media was measured as an indicator of cardiac myocyte
necrotic death. The results are expressed as the % LDH released when compared
to the total cellular LDH activity. *P<0.05, (n=8).
Fig. 8. Inhibitors of lipid peroxidation – trolox or dipyridyl – significantly
inhibit H2O2-induced necrotic death of cardiac myocytes. Cardiac myocytes
were pre-treated for 30 min with either the water-soluble Vitamin E analog,
trolox (30 μM), or with the iron chelator, dipyridyl (100 μM), then exposed to
H2O2 (200 μM) for up to 24 h. (A) Lipid peroxidation in cardiac myocytes was
determined by assessment of the oxidation of Bodipy® 581/591 C11 oxidation.
Bodipy® fluorescence results were then expressed per mg of cellular protein
*P<0.05, (n=3). (B) LDH released into the culture media was measured as an
indicator of cardiac myocyte necrotic death. The results are expressed as the %
LDH released when compared to the total cellular LDH activity. *P<0.05,
(n=6).
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and/or TUNEL assays were used to identify apoptotic cells in
previous studies [10–12]. However, DNA laddering and
TUNEL assays may also detect necrotic cells [42–46]. Long et
al. [12] additionally used annexin V staining to detect apoptotic
cells. Annexin V specifically binds phosphatidylserine, a
phosphoaminolipid that translocates to the outer leaflet of the
plasma membrane during apoptosis. However, recent evidence
suggests that phosphatidylserine translocation also occurs
during early necrosis [47], thus indicating that it is essential to
use an indicator of membrane integrity, such as propidium iodide
in conjunction with annexin V. Thus, death classified as
apoptotic in previous studies may have been necrotic or a
mixture of apoptotic and necrotic. Supporting this suggestion,
when Akao and colleagues [48] used annexin V and propidium
iodide staining, they suggested that both apoptosis and necrosis
were evident when cardiac myocytes were exposed to H2O2. It is
therefore increasingly important to use a combination of
methods to discriminate between apoptotic and necrotic forms
of cell death. When we assessed death of cardiac myocytes
following exposure to H2O2, we therefore included measure-
ments of LDH release as an indicator of plasma membrane
integrity and caspase-3 activity as an indication of apoptotic
caspase activation as well as ultrastructural evaluation usingTEM. These analyses showed ultrastructural changes following
exposure to 200 μMH2O2 were accompanied by increased LDH
release but no increase in caspase-3 activity.
4.2. H2O2 induces a form of cardiac myocyte necrosis that is
not dependent upon ATP depletion
Necrotic cell death has been considered to be a passive and
unregulated process arising from cellular ATP depletion [49–
52]. The prevailing concept of necrosis is that severe stress
results in prolonged mitochondrial transition pore opening. The
consequent mitochondrial damage compromises the production
of ATP by oxidative phosphorylation and results in cellular ATP
depletion. ATP dependent membrane pumps are inactivated as a
result of ATP depletion consequently resulting in a loss of
intracellular ion homeostasis, mitochondrial and cellular
swelling and the activation of proteases. Ultimately these
processes are thought to lead to plasma membrane rupture and
the loss of cellular contents [9,53]. Our results demonstrate that
an alternative form of necrosis exists that is not dependent upon
ATP depletion. Our findings are in agreement with those of
Cantoni et al. [54], who demonstrated that necrosis of U937
cells was not dependent on ATP depletion. In addition, Bonz et
al. [55] demonstrated that depletion of intracellular ATP and
PCr were not necessarily associated with cell death. Taken
together, these findings suggest that necrotic cell death can be
an ordered event and not simply a passive cellular response to
extracellular stimuli as has been previously proposed.
4.3. H2O2 induced cardiac myocyte necrosis is associated with
lipid peroxidation
The events in ATP-independent necrotic death therefore
require further investigation. Here, we have implicated lipid
peroxidation as an important event in this form of cell death.
Polyunsaturated fatty acids are a major component of the
plasma membrane and are susceptible to lipid peroxidation by
349T.M. Casey et al. / Biochimica et Biophysica Acta 1773 (2007) 342–351ROS. Hydroxyl radicals generated from the decomposition of
H2O2 through the iron dependent Fenton reaction initiate lipid
peroxidation by reacting with methylene groups of polyunsat-
urated fatty acids. The results from our study suggest hydroxyl
radical-mediated lipid peroxidation may be one of the events
that contribute to H2O2-induced necrosis since dipyridyl and
trolox significantly inhibited necrotic cell death and H2O2-
induced Bodipy® 581/591 C11 oxidation in cardiomyocytes.
The participation of hydroxyl radical in H2O2- induced necrosis
is also suggested by the protective effect of dipyridyl, an iron
chelator that would inhibit the Fenton reaction. In addition, the
protective effect of trolox, an antioxidant that scavenges peroxyl
radicals, indicates the involvement of lipid peroxidation in
H2O2-induced necrosis. Our findings compare well with those
of Salahudeen [38], who demonstrated that H2O2-induced lipid
peroxidation was associated with necrosis in proximal tubular
epithelial cells and that inhibition of lipid peroxidation through
the use of antioxidants reduced necrotic cell death. Taken
together, these results demonstrate that that lipid peroxidation
plays a role in mediating necrotic cell death, however, it is
currently unclear whether lipid peroxidation is the defining
event leading to necrosis and this will be an area that requires
further investigation.
4.4. Effect of calpain and cathepsin inhibitors on
H2O2-induced cardiac myocyte necrosis
It is likely that in addition to lipid peroxidation, other
processes/pathways may play a role in mediating necrotic cell
death. Syntichaki et al. [7] suggested that calpains and
cathepsins are key players in the execution of necrotic cell
death. Central to this hypothesis is the activation of calpains by
increased intracellular calcium concentrations. Once activated,
calpains can compromise the integrity of lysosomal membranes,
resulting in the release of hydrolytic enzymes such as
cathepsins. The results from our study suggest that H2O2-
induced necrotic cell death in cardiac myocytes may be caused
by factors other than calpain activation since inhibitors of
calapain 1 and cathepsin D did not reduce H2O2-induced
necrosis. However, we cannot exclude the possibility that other
protease inhibitors may have been more effective in inhibiting
necrosis and additionally that other classes of proteolytic
enzymes may be involved in mediating necrotic cell death.
4.5. MPTP opening does not mediate H2O2-induced cardiac
myocyte necrosis
Since MPTP opening is thought to trigger necrotic cell death
[25,26], we evaluated whether H2O2-induced necrosis is caused
by MPTP opening in cardiac myocytes. We measured MMP in
cardiac myocytes exposed to H2O2 since opening of the MPTP
leads to a dissipation of MMP [35]. Our results indicate that
necrosis was not preceded by a loss of MMP and that the MPTP
inhibitor CsA did not protect cells from necrosis. These results
would suggest that MPTP opening did not cause necrosis in
cardiac myocytes exposed to H2O2. These results are in contrast
to the findings of Akao et al. [48] who demonstrated thatexposure of cardiac myocytes to H2O2 promoted MPTP
opening and a subsequent dissipation of mitochondrial
membrane potential. These differences suggest that more than
one pathway may lead to necrosis.
4.6. Prevention of necrosis by the hypertrophic agents ET-1
and LIF
The hypertrophic agents, ET-1 and LIF, have previously
been shown to protect cardiac myocytes from oxidative
stress-induced death [10,56]. Our results compare well with
these findings since both ET-1 and LIF significantly
inhibited H2O2-induced necrosis. Importantly, our findings
suggest that it is possible to protect against necrotic cell
death through the activation of signal transduction pathways.
These results are therefore consistent with the suggestion
that necrosis is a regulated and controlled form of cell death
[14,15].
5. Summary
Whereas necrosis has been considered as an accidental,
unordered and passive form of cell death, the results of this
study instead suggest that necrotic cell death is an ordered event
not necessarily dependent upon the depletion of ATP. Currently,
the molecular pathways leading to necrosis are incompletely
understood, however the results of this study suggest that lipid
peroxidation plays a key role in mediating necrotic cell death.
Further elucidation of these molecular events may enable the
therapeutic modulation of necrotic cell death and therefore
provide new treatment strategies in management of diseases
including heart failure, stroke and ischemia/reperfusion injury.
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